Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) is set to issue its quarterly earnings data after the market closes on Monday, May 6th. Analysts expect the company to announce earnings of ($0.11) per share for the quarter. Tactile Systems Technology has set its FY 2024 guidance at EPS.Investors that are interested in participating in the company’s conference call can do so using this link.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last announced its quarterly earnings data on Tuesday, February 20th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.25. The company had revenue of $77.65 million for the quarter, compared to analysts’ expectations of $78.85 million. Tactile Systems Technology had a net margin of 10.39% and a return on equity of 17.08%. During the same period in the previous year, the company posted $0.29 EPS. On average, analysts expect Tactile Systems Technology to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Tactile Systems Technology Stock Down 1.1 %
Shares of NASDAQ:TCMD opened at $14.28 on Friday. The company has a market cap of $339.16 million, a price-to-earnings ratio of 11.90 and a beta of 1.23. Tactile Systems Technology has a fifty-two week low of $9.69 and a fifty-two week high of $26.11. The firm’s 50-day simple moving average is $15.30 and its 200-day simple moving average is $14.12. The company has a quick ratio of 2.99, a current ratio of 3.54 and a debt-to-equity ratio of 0.14.
Insider Buying and Selling at Tactile Systems Technology
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Recommended Stories
- Five stocks we like better than Tactile Systems Technology
- Insider Buying Explained: What Investors Need to Know
- MarketBeat Week in Review – 4/29 – 5/3
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What Are Dividend Contenders? Investing in Dividend Contenders
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.